On Jul. 31, 2026, Novartis announced the US Food and Drug Administration (FDA) approved Pluvicto® (lutetium Lu 177…
On July 9, 2026, researchers at the University of British Columbia announced they have identified a new form of hereditary…
On Nov. 17, 2025, Johnson & Johnson announced that it has entered into a definitive agreement to acquire…
On Oct. 18, 2025, GRAIL announced that positive performance and safety results from its registrational PATHFINDER 2 study…
On Oct. 8, 2025, scientists at the University of East Anglia and Oxford Biodynamics announced they have developed a…
On Mar. 24, 2025, scientists at the UCLA Health Jonsson Comprehensive Cancer Center and the University of Toronto…
On Nov. 12, 2024, a research team led by UCLA Health Jonsson Comprehensive Cancer Center investigators has shown that…
On May 15, 2024, the American Association for Cancer Research (AACR) released its biennial Cancer Disparities Progress Report…
On Apr. 15, 2021, CytoDyn announced it had executed an exclusive supply and distribution agreement with Chiral Pharma…
On Dec. 18, 2020, tthe U.S. Food and Drug Administration approved Orgovyx (relugolix) for the treatment of adult…
On Dec. 1, 2020, the FDA approved Gallium 68 PSMA-11 (Ga 68 PSMA-11) ﾖ the first drug for…
On Mar. 4, 2020, a method of testing for prostate cancer developed at the National Cancer Institute (NCI)…
On Sept. 23, 2019, the Barbara Ann Karmanos Cancer Institute and the University of Michigan Rogel Cancer Center…
On Nov. 27, 2018, the Canadian Cancer Trials Group, a new clinical trial, opened across Canada. This was…
On Jul. 17, 2018, the Keck School of Medicine of USC announced that it was leading a $26.5…
On Mar. 6, 2018, the U.S. Food and Drug Administration (FDA) authorized 23andMe’s Personal Genome Service Genetic Health…
On Dec. 13, 2017, longtime Omaha art teacher and businessman Gerald “Jerry” Pabst donated $3 million through an…
On Sept. 22, 2016, Vanderbilt University Medical Center became the world’s first site to treat a prostate cancer…
On Nov. 18, 2015, the estate of Glenn Korff gifted $5 million to the Fred & Pamela Buffett…
On May 5, 2015, Rutgers Cancer Institute of New Jersey was one of seven international sites to offer…
On Mar. 26, 2012, researchers at Stanford University School of Medicine reported study results that showed human tumors…
On Apr. 29, 2010, the FDA approved sipuleucel-T (PROVENGE), made by the Dendreon, an autologous cellular immunotherapy for…
On Dec. 9, 2008, in contrast with earlier research suggesting that dietary supplementation with selenium and vitamin E…
On Apr. 1, 2007, National Cancer Institute (NCI) researchers report that a set of genetic variations in at…
On Oct. 19, 2006, the National Cancer Institute released new data from the Cancer Genetic Markers of Susceptibility…
On Nov. 7, 2005, the National Cancer Institute launched a cancer biorepository pilot project designed to standardize biospecimen…
On Sept. 3, 2003, the death rates from the four most common cancers, – lung, breast, prostate, and…
On Jun. 24, 2003, results of the Prostate Cancer Prevention Trial (PCPT), testing the effectiveness of finasteride to…
On Mar. 24, 2003, the Winship Cancer Institute at Emory University announced it had received a $10 million…
On Oct. 16, 2002, patterns of proteins found in patients’ blood may help distinguish between prostate cancer and…